Faculty of Medicine, Division of Community Health and Humanity, Clinical Epidemiology unit, Memorial University of Newfoundland, St John's, NL, Canada.
School of Pharmacy, Memorial University of Newfoundland, St John's, NL, Canada.
J Asthma. 2022 Dec;59(12):2449-2460. doi: 10.1080/02770903.2021.2014862. Epub 2021 Dec 17.
This study investigated the association between varying cutoffs for Medication Adherence (MA) among physician-diagnosed asthma patients and subsequent association with asthma exacerbation.
We linked four administrative health databases obtained from the Population Data in British Columbia. Index cases were physician-diagnosed asthma patients between January 1, 1998, to December 31, 1999, aged 18 years and older. Patients were prospectively assessed in the follow-up period from January 1, 2000, to December 31, 2018, to identify asthma exacerbation. Two proxy measures were used to assess MA: the proportion of days covered (PDC) and the medication possession ratio (MPR). Using the generalized estimating equation (GEE) logistic regression adjusted for patient covariates, the outcome of "asthma exacerbation" was modeled against varying MA cutoffs; '≥0.90'; '0.80-0.89'; '0.70-0.799'; '0.6-0.699'; '0.50-0.599' compared to '<0.50' for both PDC and MPR.
The sample included 68,211 physician-diagnosed asthma patients with a mean age of 48.2 years and 59.3% females. The adjusted odds ratios (OR) and 95% confidence interval (CI) at the various cutoff for PDC-levels predicting asthma exacerbation events were: MA [OR = 0.84, 95% (0.82-0.86), MA [OR: 0.86, (0.83, 0.89), MA [0.91, (0.88-0.94)]; MA [0.93, (0.90-0.96)]; MA [0.95, (0.92-0.98)]; compared to MA level. Threshold levels for both the PDC and MPR measure greater than 0.80 provided optimal threshold associated with over 15% reduced likelihood of experiencing asthma exacerbations.
Intervention aimed at improving asthma exacerbation events in adult asthma patients should encourage increased medication adherence threshold level greater than 0.80.
Supplemental data for this article is available online at at www.tandfonline.com/ijas .
本研究旨在探讨不同的药物依从性(MA)截止值与随后哮喘加重之间的关系。
我们链接了来自不列颠哥伦比亚省人口数据的四个行政健康数据库。指数病例为 1998 年 1 月 1 日至 1999 年 12 月 31 日期间年龄在 18 岁及以上的被医生诊断为哮喘的患者。从 2000 年 1 月 1 日至 2018 年 12 月 31 日,对患者进行前瞻性评估,以确定哮喘加重情况。使用广义估计方程(GEE)逻辑回归调整患者协变量,以“哮喘加重”为因变量,对不同 MA 截止值进行建模:“≥0.90”;“0.80-0.89”;“0.70-0.799”;“0.6-0.699”;“0.50-0.599”与 PDC 和 MPR 的“<0.50”相比。
该样本包括 68211 名被医生诊断为哮喘的患者,平均年龄为 48.2 岁,女性占 59.3%。在不同 PDC 水平的 MA 截止值预测哮喘加重事件的调整比值比(OR)和 95%置信区间(CI)为:MA [OR = 0.84,95%(0.82-0.86)];MA [OR:0.86,(0.83,0.89)];MA [0.91,(0.88-0.94)];MA [0.93,(0.90-0.96)];MA [0.95,(0.92-0.98)];与 MA 水平相比。PDC 和 MPR 测量的阈值大于 0.80 提供了最佳阈值,可使哮喘加重的可能性降低 15%以上。
旨在改善成人哮喘患者哮喘加重事件的干预措施应鼓励提高药物依从性阈值大于 0.80。